TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bio Forte AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,251
|
1,341
|
1,479 |
Financial expenses |
1
![]() |
1
![]() |
1 |
Earnings before taxes |
44
|
38
|
94 |
Total assets |
413
|
410
|
408 |
Current assets |
384
|
361
|
384 |
Current liabilities |
114
|
126
|
139 |
Equity capital |
299
|
283
|
268 |
- share capital |
18
|
19
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.4%
|
69.0%
|
65.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.5%
|
2.8%
|
6.4% |
Return on assets (ROA) |
10.9%
|
9.5%
|
23.3% |
Current ratio |
336.8%
|
286.5%
|
276.3% |
Return on equity (ROE) |
14.7%
|
13.4%
|
35.1% |
Change turnover |
-5
|
-61
|
-167 |
Change turnover % |
0%
|
-4%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.